Translational Oncology

Article	Citations
Global colorectal cancer burden in 2020 and projections to 2040	958
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview	455
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis	124
Early lung cancer diagnostic biomarker discovery by machine learning methods	104
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis	95
3D Bioprinted cancer models: Revolutionizing personalized cancer therapy	95
Plasticity of cancer cell invasion: Patterns and mechanisms	86
The interaction mechanism between autophagy and apoptosis in colon cancer	79
Influence of cholesterol on cancer progression and therapy	68
Extracellular heat shock proteins and cancer: New perspectives	61
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles	59
HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases	57
The remodelling of actin composition as a hallmark of cancer	56
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis	53
Prognostic Indicators for Gastrointestinal Stromal Tumors: A Review	50
Regulation of CD47 expression in cancer cells	49
Chlorogenic acid: Potential source of natural drugs for the therapeutics of fibrosis and cancer	48
Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?	46
Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response	44
PLK1 inhibition-based combination therapies for cancer management	43
Drug screening model meets cancer organoid technology	38
Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes	37
S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study	37
Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images	37
Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials	36

Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer	35
Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play	35
The spontaneous remission of cancer: Current insights and therapeutic significance	35
Resistin: A journey from metabolism to cancer	35
Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma	35
Combination therapy: Future directions of immunotherapy in small cell lung cancer	34
Mesenchymal stem/stromal cells: Developmental origin, tumorigenesis and translational cancer therapeutics	34
The current landscape of the FDA approved companion diagnostics	32
Recent advances in the field of single-cell proteomics	32
CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma	31
The role of exosomal PD-L1 in tumor immunotherapy	30
Hsa_circ_0092276 promotes doxorubicin resistance in breast cancer cells by regulating autophagy via miR-348/ATG7 axis	30
Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer	30
Iron (Fe)-doped mesoporous 45S5 bioactive glasses: Implications for cancer therapy	29
Novel antigens of CAR T cell therapy: New roads; old destination	29
Superoxide-mediated ferroptosis in human cancer cells induced by sodium selenite	29
N-Acetyltransferase 10 Promotes Micronuclei Formation to Activate the Senescence-Associated Secretory Phenotype Machinery in Colorectal Cancer Cells	29
Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine	28
The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.	28
Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma	28
Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity	28
The clinical value of the changes of peripheral lymphocyte subsets absolute counts in patients with non-small cell lung cancer	28
Radiomics nomograms of tumors and peritumoral regions for the preoperative prediction of spread through air spaces in lung adenocarcinoma	28
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response	27
Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma	27
Photodynamic therapy exploiting the anti-tumor activity of mannose-conjugated chlorin e6 reduced M2-like tumor-associated macrophages	26
Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment	26
An upward 9.4 T static magnetic field inhibits DNA synthesis and increases ROS-P53 to suppress lung cancer growth	26
IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin	26
Multiparametric MRI-based radiomics analysis for the prediction of breast tumor regression patterns after neoadjuvant chemotherapy	25
Synthesis of 99mTc-labeled 2-Mercaptobenzimidazole as a novel radiotracer to diagnose tumor hypoxia	25
Transition metal ion-doped ferrites nanoparticles for bioimaging and cancer therapy	25
Advances in PSMA theranostics	25
Long non-coding RNAs in cancer stem cells	25
The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation	25
Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer	25
Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization	25
Natural flavonoids exhibit potent anticancer activity by targeting microRNAs in cancer: A signature step hinting towards clinical perfection	25
Factors associated with and risk factors for depression in cancer patients – A systematic literature review	25
MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer	25
FYN promotes gastric cancer metastasis by activating STAT3-mediated epithelial-mesenchymal transition	25
Analysis of genomics and immune infiltration patterns of epithelial-mesenchymal transition related to metastatic breast cancer to bone	24
Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers	24
Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer	24
Mass spectrometry–based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism — A Pilot study	24
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer	24
Crosstalk between oral squamous cell carcinoma cells and cancer-associated fibroblasts via the TGF-β/SOX9 axis in cancer progression	23
m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis	23
Construction of a prognostic immune signature for lower grade glioma that can be recognized by MRI radiomics features to predict survival in LGG patients	23
Driverless artificial intelligence framework for the identification of malignant pleural effusion	23

Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy	22
Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage	22
The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor	21
Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC	21
Will the clinical development of 4th-generation “double mutant active” ALK TKIs (TPX-0131 and NVL-655) change the future treatment paradigm of ALK+ NSCLC?	21
Diagnostic assessment of deep learning for melanocytic lesions using whole-slide pathological images	21
Knockdown of CDK5 down-regulates PD-L1 via the ubiquitination-proteasome pathway and improves antitumor immunity in lung adenocarcinoma	21
A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma	21
LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p	20
Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer	20
Novel prognostic model established for patients with head and neck squamous cell carcinoma based on pyroptosis-related genes	20
Emerging roles for HMGA2 in colorectal cancer	20
Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing	20
Hypomethylating Agent Azacitidine Is Effective in Treating Brain Metastasis Triple-Negative Breast Cancer Through Regulation of DNA Methylation of Keratin 18 Gene	20
Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: A multi-institutional study	20
FGF9/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer	20
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity	20
Exosomal miR-193a and let-7g accelerate cancer progression on primary colorectal cancer and paired peritoneal metastatic cancer	20
FOXO3a inhibits the EMT and metastasis of breast cancer by regulating TWIST-1 mediated miR-10b/CADM2 axis	20
Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis	19
Deep learning for predicting subtype classification and survival of lung adenocarcinoma on computed tomography	19
LncRNA HOTAIR recruits SNAIL to inhibit the transcription of HNF4α and promote the viability, migration, invasion and EMT of colorectal cancer	19
Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET/CT radiomics	19
MicroRNA-506-3p increases the response to PARP inhibitors and cisplatin by targeting EZH2/β-catenin in serous ovarian cancers	19
Radiotherapy: Brightness and darkness in the era of immunotherapy	19
GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction	19
Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type	19
Ultrasound-mediated microbubbles cavitation enhanced chemotherapy of advanced prostate cancer by increasing the permeability of blood-prostate barrier	19
KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report	19
The role of von Willebrand factor in breast cancer metastasis	18
Breast lesion characterization using Quantitative Ultrasound (QUS) and derivative texture methods	18
Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literature	18
PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression	18
Transitional dynamics of cancer stem cells in invasion and metastasis	18
Immune Suppression in Pregnancy and Cancer: Parallels and Insights	18
Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models	18
Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs	18
The PER1/HIF-1alpha negative feedback loop promotes ferroptosis and inhibits tumor progression in oral squamous cell carcinoma	18
A zinc finger family protein, ZNF263, promotes hepatocellular carcinoma resistance to apoptosis via activation of ER stress-dependent autophagy	18
Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy:	18
Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma	18
Quantifying DNA damage induced by ionizing radiation and hyperthermia using single DNA molecule imaging	17
Targeting matrix metalloproteinase MMP3 greatly enhances oncolytic virus mediated tumor therapy	17
Chemotherapeutic drugs: Cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?	17
The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy	17
Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway	17
Searching for the real function of mTOR signaling in the regulation of PD-L1 expression	17
PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma	17
Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women	17
Regulation of CD47 expression by interferon-gamma in cancer cells	17
Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs	17
CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS/NFκB pathway in ovarian cancer	16
Hypoxia-induced phenotypic transition from highly invasive to less invasive tumors in glioma stem-like cells: Significance of CD44 and osteopontin as therapeutic targets in glioblastoma	16
Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation	16
Bioengineered microfluidic blood-brain barrier models in oncology research	16
FLT3 inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor lisaftoclax (APG-2575) in preclinical models of FLT3-ITD mutant acute myeloid leukemia	16
Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?	16
Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors	16
Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models	15
Computed tomography-based radiomic model at node level for the prediction of normal-sized lymph node metastasis in cervical cancer	15
Pulmonary enteric adenocarcinoma	15
Detection of ctDNA with Personalized Molecular Barcode NGS and Its Clinical Significance in Patients with Early Breast Cancer	15
USP8 regulates liver cancer progression via the inhibition of TRAF6-mediated signal for NF-κB activation and autophagy induction by TLR4	15
Successful application of anti-CD19 CAR-T therapy with IL-6 knocking down to patients with central nervous system B-cell acute lymphocytic leukemia	15
LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis	15
Onodera's prognostic nutritional index correlates with tumor immune environment and survival in patients with oral squamous cell carcinoma undergoing chemoradiotherapy	15
Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis	15
Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6	15
A label-free microfluidic chip for the highly selective isolation of single and cluster CTCs from breast cancer patients	15
A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer	14
IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer	14
Exosomes: Insights and therapeutic applications in cancer	14
Skp2 depletion reduces tumor-initiating properties and promotes apoptosis in synovial sarcoma	14
Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum	14
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates	14
Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma	14
Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy	14
A signature of 17 immune-related gene pairs predicts prognosis and immune status in HNSCC patients	14
MET exon 14 skipping mutation, amplification and overexpression in pulmonary sarcomatoid carcinoma: A multi-center study	14
Microbiome in Intestinal Lavage Fluid May Be A Better Indicator in Evaluating The Risk of Developing Colorectal Cancer Compared with Fecal Samples	14

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma	14
Tumor-targeted pH-low insertion peptide delivery of theranostic gadolinium nanoparticles for image-guided nanoparticle-enhanced radiation therapy	14
A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma	14
Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer	14
iNKT: A new avenue for CAR-based cancer immunotherapy	14
Prediction of chemotherapy response in breast cancer patients at pre-treatment using second derivative texture of CT images and machine learning	14
Distinct tumor bacterial microbiome in lung adenocarcinomas manifested as radiological subsolid nodules	13
UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer	13
Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis	13
Multimarker scores of Th1 and Th2 immune cellular profiles in peripheral blood predict response and immune related toxicity with CTLA4 blockade and IFNα in melanoma	13
Tebentafusp in first-line melanoma trials: An outperforming outlier	13
Targeting miR-9 in Glioma Stem Cell-Derived Extracellular Vesicles: A Novel Diagnostic and Therapeutic Biomarker	13
Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?	13
Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer cells	13
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation	13
Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives	13
An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs	13
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor	13
XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB	13
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy	13
Fatty acid binding protein-4 promotes alcohol-dependent hepatosteatosis and hepatocellular carcinoma progression	13
Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells	13
R-loop modulated epigenetic regulation in T helper cells mechanistically associates coronary artery disease and non-small cell lung cancer	13
Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration	13
The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis	12
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications	12
Concerning FDA approval of trilaciclib (Cosela) in extensive-stage small-cell lung cancer	12
Prognostic implications of ENE and LODDS in relation to lymph node-positive colorectal cancer location	12
Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p/EIF5A2 pathway	12
Nephrotoxicity after radionuclide therapies	12
Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway	12
Hsa_circ_0088212-mediated miR-520 h/APOA1 axis inhibits osteosarcoma progression	12
Characterization of stanniocalcin-1 expression in macrophage differentiation	12
Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis	12
Radiosensitizing effect of gold nanoparticle loaded with small interfering RNA-SP1 on lung cancer	12
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors	12
68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study	12
A novel PAK4 inhibitor suppresses pancreatic cancer growth and enhances the inhibitory effect of gemcitabine	12
Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo	12
Platelet transfusion for cancer secondary thrombocytopenia: Platelet and cancer cell interaction	12
Integrative single-cell transcriptome analysis reveals a subpopulation of fibroblasts associated with favorable prognosis of liver cancer patients	12
Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patients	12
Single-cell RNA-seq analysis to identify potential biomarkers for diagnosis, and prognosis of non-small cell lung cancer by using comprehensive bioinformatics approaches	12
3D patient-derived tumor models to recapitulate pediatric brain tumors In Vitro	12
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer	11
C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases	11
Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine	11
Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer	11
Rova-T enhances the anti-tumor activity of anti-PD1 in a murine model of small cell lung cancer with endogenous Dll3 expression	11
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer	11
Collagen modifying enzyme P4HA1 is overexpressed and plays a role in lung adenocarcinoma	11
Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells	11
Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer	11
TIM-3 shuttled by MV3 cells-secreted exosomes inhibits CD4+ T cell immune function and induces macrophage M2 polarization to promote the growth and metastasis of melanoma cells	11
IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia	11
The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs)	11
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics	11
NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models	11
Liraglutide activates nature killer cell-mediated antitumor responses by inhibiting IL-6/STAT3 signaling in hepatocellular carcinoma	11
Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study	11
The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients	11
Luteolin promotes macrophage-mediated phagocytosis by inhibiting CD47 pyroglutamation	11
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation	11
Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma	11
Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells	11
Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas	11
LncRNA RBPMS-AS1 promotes NRGN transcription to enhance the radiosensitivity of glioblastoma through the microRNA-301a-3p/CAMTA1 axis	11
Metaplastic breast cancer: Treatment and prognosis by molecular subtype	11
Longitudinal radiomics algorithm of posttreatment computed tomography images for early detecting recurrence of hepatocellular carcinoma after resection or ablation	11
Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin	11
Tumor microenvironment disparity in multiple primary lung cancers: Impact of non-intrinsic factors, histological subtypes, and genetic aberrations	11
miR-376a inhibits glioma proliferation and angiogenesis by regulating YAP1/VEGF signalling via targeting of SIRT1	11
In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review	11
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review	11
Early risk-assessment of patients with nasopharyngeal carcinoma: the added prognostic value of MR-based radiomics	10
Sacituzumab govitecan in metastatic triple negative breast cancer (TNBC): Four design features in the ASCENT trial potentially favored the experimental arm	10
Circulating microRNAs as biomarkers to assist the management of the malignant germ-cell-tumour subtype choriocarcinoma	10
Hopes on immunotherapy targeting B7-H3 in neuroblastoma	10
CT-based radiomics model with machine learning for predicting primary treatment failure in diffuse large B-cell Lymphoma	10
Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma	10
The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy	10
TSPAN31 regulates the proliferation, migration, and apoptosis of gastric cancer cells through the METTL1/CCT2 pathway	10
Anillin facilitates cell proliferation and induces tumor growth of hepatocellular carcinoma via miR-138/SOX4 axis regulation	10
Amplification of RAD54B promotes progression of hepatocellular carcinoma via activating the Wnt/β-catenin signaling	10
Telomerase inhibitor MST-312 and quercetin synergistically inhibit cancer cell proliferation by promoting DNA damage	10
Single-treatment tumor ablation with photodynamic liposomal irinotecan sucrosulfate	10
Downregulation of miR-221–3p promotes the ferroptosis in gastric cancer cells via upregulation of ATF3 to mediate the transcription inhibition of GPX4 and HRD1	10
Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer	10
Expression pattern analysis and drug differential sensitivity of cancer-associated fibroblasts in triple-negative breast cancer	10
Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling	10
The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis	10
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma	10
STRN-ALK rearranged pediatric malignant peritoneal mesothelioma – Functional testing of 527 cancer drugs in patient-derived cancer cells	10
BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy	10
Type of chemotherapy has substantial effects on the immune system in ovarian cancer	10